Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)-Reference-Cited by-同舟云学术

Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)

Published:2020-12-18 Issue:3 Volume:73 Page:920-936
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Vandel Jimmy¹,Dubois‐Chevalier Julie¹,Gheeraert Céline¹,Derudas Bruno¹,Raverdy Violetta²,Thuillier Dorothée²,Gaal Luc³⁴,Francque Sven⁴⁵,Pattou François²,Staels Bart¹,Eeckhoute Jérôme¹,Lefebvre Philippe¹

Affiliation:

1. Univ. LilleInserm, CHU Lille Institut Pasteur de Lille U1011‐EGIDLille France

2. Univ. LilleInserm, CHU Lille U1190‐EGIDLille France

3. Department of Endocrinology, Diabetology and Metabolism Antwerp University Hospital Edegem (Antwerp) Belgium

4. Laboratory of Experimental Medicine and Pediatrics (LEMP) University of Antwerp Wilrijk (Antwerp) Belgium

5. Department of Gastroenterology and Hepatology Antwerp University Hospital Edegem (Antwerp) Belgium

Funder

Fondation pour la Recherche Médicale

Fondation de France

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31312

Reference50 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. Mechanisms of NAFLD development and therapeutic strategies

4. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

5. Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex‐specific effects of PNPLA3 I148M;Liver International;2024-09-11

2. Metabolic dysfunction‐associated steatohepatitis exhibits sex differences in people with HIV;HIV Medicine;2024-08

3. Implications of innate immune sexual dimorphism for MASLD pathogenesis and treatment;Trends in Pharmacological Sciences;2024-07

4. Nuclear receptors: pathophysiological mechanisms and drug targets in liver disease;Gut;2024-06-11

5. Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression;Journal of Clinical Investigation;2024-04-01